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Abstract
There are no studies investigating the effect of the contrast infusion on the sensitivity and specificity
of the main Doppler criteria of renal artery stenosis (RAS). Our aim was to evaluate the accuracy
of these Doppler criteria prior to and following the intravenous administration of perfluorocarbon
exposed sonicated albumin (PESDA) in patients suspected of having RAS. Thirty consecutive
hypertensive patients (13 males, mean age of 57 ± 10 years) suspected of having RAS by clinical
clues, were submitted to ultrasonography (US) of renal arteries before and after enhancement
using continuous infusion of PESDA. All patients underwent angiography, and haemodynamically
significant RAS was considered when ≥50%. At angiography, it was detected RAS ≥50% in 18
patients, 5 with bilateral stenosis. After contrast, the examination time was slightly reduced by
approximately 20%. In non-enhanced US the sensitivity was better when based on resistance index
(82.9%) while the specificity was better when based on renal aortic ratio (89.2%). The predictive
positive value was stable for all indexes (74.0%–88.0%) while negative predictive value was low
(44%–51%). The specificity and positive predictive value based on renal aortic ratio increased after
PESDA injection respectively, from 89 to 97.3% and from 88 to 95%. In hypertensives suspected to
have RAS the sensitivity and specificity of Duplex US is dependent of the criterion evaluated.
Enhancement with continuous infusion of PESDA improves only the specificity based on renal
aortic ratio but do not modify the sensitivity of any index.
Introduction
Renal artery stenosis is the most frequent cause of second-
ary hypertension [1] which is potentially treatable with
angioplasty, endovascular stent placement or surgical
revascularization [2,3]. The angiography remains the gold
standard, however, is invasive, expensive, and potentially
harmful specially in patients with compromised renal
function or diabetes [4]. Over the past few years, there has
been extensive research for a reliable, noninvasive, and
nonionizing imaging method to screen for renal artery
stenosis (RAS) [5]. Magnetic resonance (MR) angiogra-
phy, captopril renography and duplex ultrasonography
have all been assessed for this purpose [6,7]. Duplex ultra-
sonography (US) is safe and widely available, but its use
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as a screening tool of renal artery stenosis does not have
universal acceptance because of the lack of standardiza-
tion in examination protocols and diagnostic criteria, as
well as the wide differences in reported accuracy among
different laboratories [8,9]. In addition, despite the use of
color Doppler and other technological improvements, the
localization of the main renal arteries deep within the
abdomen has rendered direct visualization of these vessels
difficult [10]. There is a 10 to 20 percent rate of failure due
to the operator's inexperience, the presence of obesity,
overlying bowel gas or respiratory motion [11]. 
The proposed criteria for the detection of renal artery ste-
nosis by direct Doppler include an increased peak systolic
velocity, an increase in renal aortic ratio and also an
increased resistance index [12]. The mean sensitivity and
specificity of the Duplex US based on these criteria varies,
respectively, from 10 to 93% and from 37% to 100%,
according to different reports [8-10,12-20]. There are few
reports comparing these criteria for the detection of RAS
[15].
Recently, the use of microbubble echo-enhancing agents
in combination with harmonic Doppler imaging has been
proposed to improve Doppler signal intensity in multiple
vascular sites [21]. Thus, it would be expected to improve
the operator's ability to visualize the renal arteries, and to
significantly reduce the number of equivocal examina-
tions [11,21-23]. In addition, contrast-enhanced har-
monic Doppler US can currently provide objective
functional assessment of RAS through analysis of time-
intensity renal enhancement curve [22]. MISSOURIS et al
[23] have reported data of microbubble Levovist® echo-
enhancing ultrasonography in hypertensives with renal
artery stenosis. They demonstrated a sensitivity of 85%
and a specificity of 79% without contrast and a sensitivity
of 94% and a specificity of 88% with contrast, besides an
important reduction in the time of procedure. The echo-
enhancing agent PESDA (perfluorocarbon exposed soni-
cated albumin) is a second-generation agent, containing
high molecular weight gas, whose use results in higher sta-
bility and better reflections of Doppler signs [24]. The
PESDA is broadly used in echocardiography [24], but till
date there is no studies using PESDA contrast in echo-
enhanced US of renal arteries. Also there are no studies
that investigate the effect of the contrast infusion on the
sensitivity and specificity of the different Doppler crite-
rion mentioned above. 
The purpose of our study was to evaluate the accuracy of
the main color Doppler criteria of the renal arteries prior
to and following the intravenous administration of
PESDA in patients suspected of having renal arterial sten-
osis. These results were compared with those from con-
ventional angiography, which was regarded as the
standard of reference. As a secondary objective, the feasi-
bility, time of examination and safety of US with PESDA
infusion was analyzed. 
Methods
Study Population
Thirty patients (13 males/ 17 females), with a mean age of
57 ± 12 years (range 16–77 years) were enrolled in the
study, that was performed at Heart Institute of São Paulo
University. The only inclusion criterion was a clinical sus-
picion of renal arterial stenosis that required conventional
or digital subtraction angiography for diagnosis. The sus-
picion of renovascular hypertension was based on the
presence of one or more of the following clinical features:
resistant hypertension, progressive renal failure with no
recognized cause, atherosclerotic disease in other circula-
tory site (coronary, peripheral or cerebrovascular disease),
renal failure induced by ACE inhibitors; renal asymmetry;
retinopathy grade lll or lV (Keith Wagener) with diastolic
blood pressure over 125 mmHg [1]. Exclusion criteria
were as follows: patients with a renal transplant; patients
who had a renal arterial stent and those referred because
they were suspected of having renal arterial restenosis;
patients who received any iodinated agent in the previous
24 hours, and patients with acute myocardial infarction or
stroke. All patients underwent conventional angiography
or digital subtraction angiography. 
The patients were assigned randomly in a 2-steps imaging
protocol: 1) acquisition of a baseline non-enhanced Dop-
pler ultrasound study by a Sequoia Echography System
(Acuson, Siemens, Mountain View, CA, USA); 2) a contin-
uos infusion of contrast PESDA, 0,1 ml per kg of weight in
a rate of infusion of 2 ml per minute; c) after infusion, we
adjust the gain according to the observed gain intensity
increase for optimal filling of the vessel lumen in color
mode and delineation of the spectrum envelope in duplex
mode. The ultrasound scans were done in different posi-
tions to evaluate all segments of the main renal arteries: a)
supine position to visualize the origin and proximal por-
tion, b) epigastric transverse scans of the aorta to identify
the right artery (anterolateral) and left artery (posterola-
teral), c) the sagital or coronal scan from a flank approach
to identify the medium and distal portions of the arteries
[[20],26,27]. Peak systolic (PSV) and diastolic (PDV)
velocities of the aorta and renal arteries, and calculation of
resistance index (RI), pulsatility index (PI) and renal aor-
tic ratio (RAR) were obtained in all segments of renal
arteries [[20],26-27].
The following spectral Doppler diagnostic criterion for
renal arterial stenosis were used: a) PSV > 150 cm/s [26-
27]; b) RAR > 3.0 [18]; c) RI > 0,80 [17]. The same exam-
iner performed all examinations and the confirmation of
the presence of stenosis was done in consensus withJournal of Negative Results in BioMedicine 2004, 3:3 http://www.jnrbm.com/content/3/1/3
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another examiner, both of them blinded to the results of
the angiography.
We also collected clinical data, including number of
drugs, serum creatinine and values of blood pressure in
baseline conditions. 
The results of PESDA-enhanced and non-enhanced ultra-
sound examinations were compared with those from
intraarterial angiography. A hemodynamically significant
stenosis was defined as diameter reduction of 50% or
more at angiography, because it has been widely used in
the recent literature [13]. The radiologist and clinician
interpreting the study were blinded to the Doppler exam-
ination results. 
Secondary efficacy variables included the duration of each
Doppler examination, the detection of supernumerary
arteries and adverse effects. 
The study was approved according to local legal require-
ments and informed consent was obtained before ultra-
sound examination from all patients.
Results
Patient Characteristics 
All patients underwent digital subtraction angiography
and non-enhanced US. One patient did not receive the
infusion of contrast, because the venous access was not
possible. Renal arterial stenosis of 50% or greater was
detected at angiography in 18 (60%) patients, 5 of whom
had bilateral stenosis. Renal arterial stenosis was excluded
in 12 patients. Thus, stenosis by angiography was detected
in 23 arteries, while 37 arteries did not present. The clini-
cal and demographic data of patients according to the
presence of stenosis are presented in the Table 1. The
patients with stenosis were older than patients with no
stenosis (p = 0.013), while we did not observe differences
in the other demographic and clinical data. 
Feasibility
Overall, all patients had the renal arteries assessable with
non-enhanced US or after injection of PESDA, although in
one patient with a high body mass index, the assessment
was better after contrast. Despite an expectation of at least
20% accessory arteries, we did not find any in our
population.
Accuracy
As stenosis is mostly in ostium and proximal portion of
the arteries, we considered for diagnosis of renal artery ste-
nosis the indexes obtained by echo-Doppler in these arte-
rial segments. The mean values of PSV, PDV, RAR, RI and
PI in these segments are showed in the tables 2 and 3. In
the ostium, the values of PSV and RAR were higher in
arteries with stenosis, in either enhanced or non-
enhanced US. In the proximal segment, only RAR values
were higher in arteries with stenosis, in both enhanced
and non-enhanced US. 
The sensitivity, specificity, positive predictive value and
negative predictive value of each Doppler index for the
detection of RAS (Table 4) were calculated based on the
values standardized in the literature. In terms of renal
arteries, we observe that the sensitivity and specificity
depend on the index used. Thus, in non-enhanced US the
sensitivity was better when based on RI (82.9%) while the
specificity was better when based on RAR (89.2%). The
PPV was stable for all indexes (74.0%–88.0%) while NPV
was low (44%–51%). The specificity and PPV based on
RAR increased after PESDA injection respectively, to
97.3% and 95%. 
The receiver operating characteristic curves for each Dop-
plerdiagnostic criterion showed that the area under the
receiver operating characteristic curve for resistance index
was greater than the area under the curve for peak systolic
velocity and renal aortic ratio. For renal aortic ratio, the
cutoff point that provided the best accuracy, 2.7 gave a
specificity of 96% but a low sensitivity (60%). For peak
systolic velocity, no precise cutoff point could be
identified between arteries with stenosis and those with-
out stenosis. For resistance index, a threshold of 0.8 led to
a sensitivity of 70% and a low specificity of 56.8%. 
Table 1: Demographic and clinical data of 30 patients according to the presence of RAS at angiography
Patients with no stenosis (n = 12) Patients with stenosis (n = 18) p
Age (years) 43 ± 15 57 ± 14 0,013*
BMI 25,5 ± 5,2 26,5 ± 3,4 0,528
SP (mmHg) 158 ± 29 162 ± 26 0,738
DP (mmHg) 97 ± 15 96 ± 16 0,900
HR 74 ± 12 74 ± 11 0,866
Cr 1,21 ± 0,51 2,01 ± 1,50 0,088
BMI: corporeal mass index SP: systolic pressure DP: diastolic pressure; HR: heart rate Cr: serum creatinine (normal < 1,50 mg/dl); RAS = renal 
artery stenosisJournal of Negative Results in BioMedicine 2004, 3:3 http://www.jnrbm.com/content/3/1/3
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Table 2: Mean values of Doppler indexes obtained with non-enhanced or enhanced with PESDA ultrassonography in the ostium of renal 
arteries
Non-enhanced Enhanced p
Arteries without 
stenosis n = 37
Arteries with 
stenosis n = 23
Arteries without 
stenosis n = 37
Arteries with 
stenosis n = 23
Stenosis vs no 
stenosis
Enhanced vs no 
enhanced
PSV (cm/s) 1,49 ± 0,76 2,26 ± 1,15 1,49 ± 0,65 2,01 ± 1,27 0,001 0,975
PDV (cm/s) 0,31 ± 0,25 0,42 ± 0,34 0,32 ± 0,19 0,37 ± 0,38 0,229 0,596
RRA 1,43 ± 0,67 2,36 ± 1,34 1,19 ± 0,54 2,19 ± 1,45 <0,001 0,145
RI 0,77 ± 0,20 0,84 ± 0,12 0,79 ± 0,11 0,76 ± 0,27 0,601 0,291
PI 1,83 ± 0,90 2,23 ± 0,97 1,97 ± 0,77 1,97 ± 0,99 0,332 0,588
PSV: peak systolic velocity; PDV: peak diastolic velocity; RAA: renal/aortic ratio RI: resistance index; PI: pulsatility index; US = ultrasonography
Table 3: Mean values of Doppler indexes obtained with non-enhanced or enhanced with PESDA ultrassonography in the proximal 
portion of renal arteries
Non-enhanced Enhanced p
Arteries without 
stenosis n = 37
Arteries with 
stenosis n = 23
Arteries without 
stenosis n = 37
Arteries with 
stenosis n = 23
Stenosis vs no 
stenosis
Enhanced vs 
no enhanced
PSV (cm/s) 1,56 ± 0,79 2,12+/-1,22 1,68+/-0,86 2,01+/-1,27 0,059 0,973
PDV (cm/s) 0,36+/-0,22 0,38+/-0,31 0,33+/-0,21 0,38+/-0,36 0,589 0,618
RAR 1,54+/-0,84 2,16+/-1,25 1,30+/-0,60 1,98+/-1,36 0,008 0,103
RI 0,76+/-0,11 0,83+/-0,11 0,78+/-0,13 0,76+/-0,26 0,193 0,793
PI 1,74+/-0,68 2,31+/-0,91 2,06+/-1,01 2,05+/-1,07 0,526 0,375
PSV: peak systolic velocity; PDV: peak diastolic velocity; RAA: renal/aortic ratio RI: resistance index; PI: pulsatility index; US = ultrasonography
Table 4: Sensitivity and specificity of non-enhanced and enhanced Doppler US for the detection of RAS in 60 arteries
a) Non-enhanced
Sensitivity Specificity PPV NPV
RRA (<3,0) 56,2% 89,2% 88% 44%
PSV (<150) 69,7% 64,9% 75% 45%
RI (<0,80) 82,9% 56,8% 74% 51%
b) Enhanced
Sensitivity Specificity PPV NPV
RRA (<3,0) 33,3% 97,3% 95% 40%
PSV (<150) 61,9% 64,9% 72% 42%
RI (<0,80) 76,2% 43,2% 66% 42%
RRA: ratio renal/aortic PSV: peak sistolyc velocity(cm/s) RI: resistive index PPV = positive predictive value, NPV = negative predictive value RAS = 
Renal artery stenosis; US = ultrasonographyJournal of Negative Results in BioMedicine 2004, 3:3 http://www.jnrbm.com/content/3/1/3
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Secondary variables and safety
The median examination time was 35 minutes for
enhanced Doppler US and 29 minutes for non-enhanced
Doppler US, i.e., a small but significant reduction of 17%
(p = 0.03). Only one patient presented adverse events to
be potentially related to the injection of PESDA, including
sensation of coldness, palpitation and dyspnea. There was
no severe adverse event. 
Discussion
Although the technique of renal arterial US scanning has
been well established for years, a lot of difficulties in reli-
ably identifying main and accessory renal arteries remain
[8-10,25]. Most of these dificulties are related to the
patient obesity, the presence of bowel gas, excessive respi-
ratory movement, and the depth and tortuosity of the
renal arteries [8,16]. The time expended in the
examination can be too long as almost 60 minutes [19],
and failure of technique varies from 9 to 25%. In our
study, non-enhanced Doppler US showed a feasibility rate
of 100%, similar to some single centers, but higher than
the majority of studies using this technique (58–90%)
[11]. Indeed, two recently published studies reported fea-
sibility not exceeding 11% and 12% [22,23]. One of the
reasons of our high rate of feasibility probably is related to
the quality of the machine, which allowed a scan imaging
with an excellent definition. To our knowledge, the
present study is the first randomized study in a selected
group of hypertensive patients in which renal arterial
color Doppler flow US with and without a continuous
infusion of PESDA was compared against the reference
standard of angiography. The infusion of PESDA did not
alter the feasibility that remains 100%. In a multicentric
study [11] using Levovist as the US contrast, the infusion
increased by 20% the number of patients in whom renal
arteries could be evaluated, including difficult cases such
as those involving patients who are obese and patients
with impaired renal function. However, some centers par-
ticipating of the study also presented a feasibility of 100%
and the Levovist infusion did not interfere in the results.
In our study only one obese patient had a better visualiza-
tion of renal artery after contrast infusion, and in all
patients with renal failure, the non-enhanced US was able
to localize renal arteries. 
The most important conclusion from this study is that
both sensitivity and specificity of Doppler US of renal
arteries are strongly dependent on the criterion used, and
the infusion of PESDA contrast seems not to improve it
significantly, although we observe a slight increase in spe-
cificity. Thus, the best sensitivity was obtained when
based on resistance index <0.8 (82.9%) but at expense of
a low specificity (56.8%). On the other hand, the best spe-
cificity was obtained with renal aortic ratio >3 (89.2%),
but the sensitivity was low (56.2%). In addition, the sen-
sitivity and specificity for a peak systolic velocity of 1.5 m/
sec showed intermediate values, respectively, 61.9% and
64.9%. An analysis of previously published studies [8-
10,12,15,16,20] based on non enhanced Doppler evalua-
tion of the renal artery clearly shows that the diagnostic
criteria and respective threshold values fluctuate from one
report to the other. Miralles et al [15] reported a sensitivity
of 87.3% and a specificity of 91.5% for a higher peak
systolic velocity (>1.98 m/sec) and a higher renal aortic
ratio (>3.3), while Olin et al [12] reported a sensitivity of
98% and specificity of 98% for a quite similar criteria.
Helenon et al [10] quoted a sensitivity of 89% and a spe-
cificity of 99% with use of a peak systolic velocity cutoff
point similar to our study (1.5 m/sec) but taking into
account the presence of poststenotic turbulence and not
renal aortic ratio. Moreover, in the multicentric study
cited above comparing non enhanced and enhanced Dop-
pler US [11], renal aortic ratio was more accurate than
peak systolic velocity in the diagnosis of a renal arterial
stenosis greater than 50%, but it was difficult to determine
a precise cutoff point. In the same study, the authors dem-
onstrated, in terms of patients, a sensitivity of 80.0% and
a specificity of 80.8%, but according to renal arteries the
sensitivity was lower (66.7%) and the specificity was
higher (90.4%). These latter results were quite similar to
our results based on RAR criteria, also evaluated according
to renal arteries. These facts, determination of accuracy in
terms of renal arteries and not in terms of patients, can
explain in part the differences encountered between our
conclusions and those from the studies mentioned above. 
The continuous infusion of PESDA contrast increased
moderately the specificity for renal aortic ratio criteria
from 89.2% to 97.3% but at the expense of a significant
decrease of sensitivity from 56.2% to 33.3%. For the
another criteria, peak systolic velocity and resistance index
the infusion of PESDA decreased mildly or did not affect
the sensitivity and specificity. MISSOURIS et al [23] have
reported an increase of sensitivity from 85% to 94% and
of specificity from 79% to 88% after injection of micro-
bubble Levovist® in hypertensives with renal artery steno-
sis. In a more recent multicentric study the contrast
Levovist did not affect either sensitivity or specificity: sen-
sitivity was 80.0%–83.7%, whereas specificity moderately
increased from 80.8% to 83.6% or 86.2%, depending on
the subgroups of comparable patients. In two single-
center studies in which the value of Doppler US examina-
tion after intravenous injection of contrast agents for the
diagnosis of renal arterial was also evaluated it was
demonstrated an improvement in sensitivity, which
increased from 83% to 95% in one study and from 75%
to 100% in the other [22,23]. However, both of these
studies were based on a limited number of patients with a
very low feasibility rate of 11% and 12% at baseline exam-
ination, respectively. In addition, Melany et al [22]Journal of Negative Results in BioMedicine 2004, 3:3 http://www.jnrbm.com/content/3/1/3
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reported that contrast Levovist injection did not improve
specificity, as we also demonstrated with PESDA infusion. 
There is no consensus whether contrast agent injection
potentially reduces examination duration. In our study,
we found a significant reduction of mean examination
time after contrast infusion (17%). In other study, it was
reported that the use of Levovist dramatically reduced the
mean examination time from 24.5 minutes to 13.5 min-
utes [23]. This advantage could be of potential economic
interest, but subsequent studies have to confirm more sig-
nificant differences. 
PESDA was well tolerated and did not compromise the
safety of US. This excellent patient tolerance has already
been demonstrated in stress echocardiograph studies that
used PESDA as contrast agent [24]. 
The small number of patients impose some limitations to
the present study, However, the high prevalence of renal
artery stenosis in this selected group of hypertensives
counterbalance this limitation. 
In conclusion, the detection of renal artery stenosis by
Doppler US depends on the criteria used and infusion of
PESDA contrast seems not to improve the accuracy,
despite a reduction in the examination duration and an
increase in  specificity based on  one Doppler criterion.
Also, the feasibility of US is dependent of the quality of
the machine, and the infusion of contrast does not add
advantages if the performance of the US machine is excel-
lent. However, it remains unknown if the PESDA infusion
can improve feasibility if the machine does not have a
good imaging quality. So, there is a need for establishing
a consensus opinion regarding Doppler useful criteria and
thresholds for the diagnosis of renal arterial stenosis,
regardless of the US equipment used or infusion of ultra-
sonographic contrast.
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